1. Skip to navigation
  2. Skip to content
  3. Skip to sidebar
Consumer Affairs

Fruta Planta/Reduce Weight Dietary Supplement Recalled.

PRock Marketing, LLC is pulling all weight loss formulas and variation of formulas of the product

01/05/2011 | James Limbach | ConsumerAffairs.com | Recalls

All Formulas of Reduce Weigh Fruta Planta/Reduce Weight products are being recalled.

A lab analysis by the Food and Drug Administration (FDA) has determined the products pose a threat to consumers because they contain the pharmaceutical ingredient Sibutramine, a controlled substance that was withdrawn from the market in October 2010 for safety reasons.

Sibutramine is known to increase blood pressure and/or pulse rate in some patients substantially and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. However, no illnesses or injuries have been reported to the company to date in connection with these products.

All lots pulled

PRock Marketing, LLC, located in central Florida -- an authorized U.S. distributor of the product -- is recalling all lots of the product:

  1. Fruta Planta; 30 Capsules/Box
  2. Reduce Weight Fruta Planta; 30 capsules/Box; 30 capsules/Bottle
  3. Reduce Weight Fruta Planta; 30 capsules/ Pink Box;
  4. Reduce Weight Fruta Planta; 30 capsules/Box With GMP Sticker
  5. Reduce Weight Fruta Planta; 30 Capsules/Box
  6. Reduce Weight; 30 Capsules/Box

 

The products listed above were sold and distributed nationwide via the Internet by several different Websites and can also be found in some retail locations.

PRock Marketing stresses that there is no safe formula on the US market -- that all versions of Fruta Planta contain Sibutramine. That means all versions of the formula are unsafe and should not be purchased from any source.

Consumer advice

Consumers are advised to destroy the above products or return them to the company in Wilton Manors, Florida 33305. Those with questions may contact the company Monday through Friday 10:00 am to 4:30 pm EST at 877-225-1009.

Any adverse reactions or quality problems experienced with the use of these products may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail using use postage-paid, pre-addressed Form FDA 3500 and mailing to the address on the pre-addressed form or by fax at 1-800-FDA-0178.

Quantcast